Why Ocugen Shot 8% Higher on Friday
Ocugen (NASDAQ: OCGN), one of the more talked-about meme stocks in the biotech sector, closed out this week on a high note. The company's shares flew more than 6% higher, on the back of generally positive developments for coronavirus vaccines, and perhaps some fresh news about employee incentives.
On Friday, the Food and Drug Administration (FDA) granted authorization for booster shots of the coronavirus vaccines from both Moderna and the partnership of pharmaceutical sector mainstay Pfizer and BioNTech to all adult Americans. It had previously turned on the green light for a booster of Johnson & Johnson's one-shot jab.
Image source: Getty Images.
Source Fool.com
